Raia DrogasilBSP:RADL3 +1.08%91 Days Payable is 85.02 as of Mar. 2026, which is 19% above its 10-year median of 71.51. GuruFocus rates BSP:RADL3 with a GF Score™ of 91/100 and a GF Value™ of R$29.95 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Raia Drogasil ranks better than 58.81% on this metric.
The historical rank and industry rank for Raia Drogasil's Days Payable or its related term are showing as below:
BSP:RADL3'
s Days Payable Range Over the Past 10 Years
Min: 66.36 Med: 71.51 Max: 74.23
Current: 72.74
During the past 13 years, Raia Drogasil's highest Days Payable was 74.23. The lowest was 66.36. And the median was 71.51.
BSP:RADL3's Days Payable is ranked better than 58.81% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs BSP:RADL3: 72.74
Raia Drogasil's Days Payable
increased
from Mar. 2025 (83.92) to Mar. 2026 (85.02).
It may suggest that Raia Drogasildelayed paying its suppliers.
Raia Drogasil Days Payable Related Terms
Raia Drogasil Days Payable Historical Data
* Premium members only.
The historical data trend for Raia Drogasil's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Raia Drogasil's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raia Drogasil Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Days Payable distribution charts can be found below:
* The bar in red indicates where Raia Drogasil's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Raia Drogasil's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raia Drogasil (BSP:RADL3) has a Days Payable of 85.02 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Raia Drogasil and its competitors. This is 19% above median its historical median of 71.51. Over the past decade, Raia Drogasil's Days Payable has ranged from 66.36 to 74.23. According to the industry distribution chart, Raia Drogasil ranks #250 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 41.2%.
Is Raia Drogasil's Days Payable too high?
Raia Drogasil's current Days Payable of 85.02 is 19% above median its 10-year median of 71.51. Over the past 10 years, this metric has ranged from a low of 66.36 to a high of 74.23. The Healthcare Providers & Services industry median Days Payable is 58.00. Raia Drogasil's value of 85.02 is 46.6% above this industry median. Based on the distribution chart, Raia Drogasil ranks #250 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Raia Drogasil has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Raia Drogasil ranks #250 out of 607 companies for Days Payable. This puts Raia Drogasil in the upper half of its industry. The industry median Days Payable is 58.00. Raia Drogasil's value of 85.02 is 46.6% above this benchmark. Historically, Raia Drogasil's own Days Payable has ranged from 66.36 to 74.23 over the past decade. While the company's 10-year median is 71.51 vs. the industry median of 58.00, Raia Drogasil has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raia Drogasil's current Days Payable of 85.02 is 46.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Raia Drogasil and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raia Drogasil's current Days Payable is 85.02, which is 19% above median its own 10-year median of 71.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$29.95, compared to a current price of R$16.88 — trading 43.6% below its estimated fair value. The current Days Payable is 85.02, which is 19% above median its 10-year median of 71.51 and 46.6% above the Healthcare Providers & Services industry median of 58.00. Raia Drogasil's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Days Payable is 85.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?
Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued.
The current stock price of R$16.88 is trading 43.6% below its estimated GF Value™ of R$29.95.
GuruFocus considers Raia Drogasil to be Significantly Undervalued.
Key valuation signals for BSP:RADL3:
Days Payable: 85.02 (19% above median its 10-year median of 71.51)
GF Value™: R$29.95 vs. price of R$16.88 (43.6% below fair value)
Industry Position: 46.6% above the Healthcare Providers & Services median (#250 of 607)
No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
91GF Score
Get the complete analysis for BSP:RADL3
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:RADL3 has been successfully added to your 
